William E. Kennard - 20 Jun 2023 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Anna Nazarenko, Authorized Signer
Issuer symbol
MET
Transactions as of
20 Jun 2023
Net transactions value
+$43,780
Form type
4
Filing time
22 Jun 2023, 16:17:57 UTC
Previous filing
16 Jun 2023
Next filing
02 Aug 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $43,780 +803 +2.2% $54.52 36,523 20 Jun 2023 Direct F1
holding MET Common Stock 10 20 Jun 2023 By the MetLife Policyholder Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
F2 Shares held in trust under the MetLife Policyholder Trust established to hold shares of common stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.